IFNA7 Human, Sf9

Interferon-alpha 7 Human Recombinant, Sf9

Recombinant Human IFNA7, produced in Sf9 Baculovirus cells, is a single, glycosylated polypeptide chain (175 amino acids, 24-189) with a molecular weight of 20.7kDa. It features a C-terminal 6-amino acid His-Tag and is purified using proprietary chromatographic methods.
Shipped with Ice Packs
Cat. No.
BT25156
Source
Sf9, Baculovirus cells.
Appearance
Clear, sterile-filtered solution.

IFA1 Porcine

Interferon-alpha 1 Porcine Recombinant

Recombinant porcine IFA1, produced in HEK293 cells, is a single, glycosylated polypeptide chain containing 176 amino acids (a.a 24-189). With a molecular mass of 20.2 kDa, IFA1 is fused to a 6 amino acid His-tag at the C-terminus and purified using proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT25263
Source

HEK293 cells.

Appearance
Sterile, colorless solution.

IFN a 2b Human, Yeast

Interferon-Alpha 2b Human Recombinant, Yeast

Recombinant Human Interferon-alpha 2b, produced in yeast, is a single, glycosylated polypeptide chain with a molecular weight of approximately 19.3 kDa, comprising 165 amino acids. The purification process involves proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT26246
Source
Saccharomyces cerevisiae.
Appearance
Sterile, lyophilized powder with a white color.

IFN b 1a Human

IFN-Beta 1a Human Recombinant

Recombinant Human IFN-beta 1a, produced in Chinese Hamster Ovarian (CHO) cells, is a single, glycosylated polypeptide chain consisting of 166 amino acids. It has a molecular weight of 22.5 kDa. Purification is achieved using proprietary chromatographic methods.
Shipped with Ice Packs
Cat. No.
BT26295
Source
CHO (Chinese Hamster Ovarian) cells.

IFN b 1b Human

IFN-Beta 1b Human Recombinant

Recombinant Human IFN beta 1b, produced in E. coli, is a single, non-glycosylated mutein (variant) of the human IFN beta-1b polypeptide chain. This protein, with a molecular mass of 18510.86 Dalton, comprises 165 amino acids. The IFN-beta gene, derived from human fibroblasts, was cloned and modified to replace the Cysteine residue at position 17 with Serine. The purification of IFN beta-1b is achieved through proprietary chromatographic methods.
Shipped with Ice Packs
Cat. No.
BT26384
Source
Escherichia Coli.
Appearance
The product appears as a sterile, filtered, white powder, freeze-dried for preservation.

IFNAR1 Mouse

Interferon Alpha And Beta Receptor Mouse Recombinant

Recombinant IFNAR1 from mice, produced in Sf9 Baculovirus cells, is a single, glycosylated polypeptide chain. It comprises 411 amino acids (27-429a.a) and exhibits a molecular mass of 46.8 kDa. On SDS-PAGE, the apparent molecular size will be approximately 40-57 kDa. The IFNAR1 protein is fused to a 6 amino acid His-tag at the C-terminus and undergoes purification using proprietary chromatographic methods.
Shipped with Ice Packs
Cat. No.
BT27445
Source
Sf9, Baculovirus cells.
Appearance
A clear, sterile solution.

IFNAR2 Human

Interferon Alpha And Beta Receptor Subunit 2 Human Recombinant

Recombinant IFNAR2, human, produced in Baculovirus is a single, glycosylated polypeptide chain. This protein consists of 456 amino acids, spanning from residue 27 to 243, with a molecular weight of 51.7 kDa. A 239 amino acid hIgG-His tag is fused to the C-terminus of IFNAR2. The protein undergoes purification using proprietary chromatographic methods.
Shipped with Ice Packs
Cat. No.
BT27559
Source

Sf9, Baculovirus cells.

Appearance
A clear, colorless solution that has been sterilized by filtration.

IFNG 139 a.a. Human

Interferon-gamma 139 a.a Human Recombinant

Recombinant human interferon gamma (IFNG), consisting of 139 amino acids, is produced in E. coli. This non-glycosylated polypeptide encompasses amino acids 24 to 161 and exhibits a molecular weight of 16.3 kDa. The purification process involves proprietary chromatographic techniques to ensure high purity.
Shipped with Ice Packs
Cat. No.
BT27643
Source
Escherichia Coli.
Appearance
The product appears as a clear, sterile solution after filtration.

IFNG Canine

Interferon-gamma Canine Recombinant

Recombinant Canine IFNG, expressed in E. coli, is a non-glycosylated, homodimeric protein. It consists of two identical polypeptide chains, each comprising 143 amino acids, resulting in a molecular weight of 16.9 kDa. The purification process involves proprietary chromatographic techniques to ensure high purity.
Shipped with Ice Packs
Cat. No.
BT27713
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized powder.

IFN a 2b Human

IFN-Alpha 2b Human Recombinant

Recombinant Human IFN-a 2b, produced in E. coli, is a non-glycosylated polypeptide chain consisting of 166 amino acids. With a molecular weight of 19400 Daltons, it differs from IFN-alpha 2a by a single amino acid at position 23 (arginine in IFN-alpha 2b instead of lysine in IFN-alpha 2a). The IFN-alpha 2b gene originates from human leukocytes, and the protein is purified using proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT26060
Source
Escherichia Coli.
Appearance
Sterile Filtered White Lyophilized (Freeze-Dried) Powder
Definition and Classification

Interferons (IFNs) are a group of signaling proteins produced and released by host cells in response to the presence of pathogens, such as viruses, bacteria, and parasites . They belong to the larger class of proteins known as cytokines, which are crucial for communication between cells to trigger the protective defenses of the immune system . Interferons are named for their ability to “interfere” with viral replication within host cells .

Interferons are classified into three main types based on the type of receptor through which they signal:

  • Type I Interferons: This group includes IFN-α, IFN-β, IFN-ε, IFN-κ, and IFN-ω. They bind to a specific cell surface receptor complex known as the IFN-α/β receptor (IFNAR) .
  • Type II Interferons: This group consists of IFN-γ, which binds to the IFN-γ receptor (IFNGR) .
  • Type III Interferons: This group includes IFN-λ1, IFN-λ2, IFN-λ3, and IFN-λ4, which signal through the IFN-λ receptor (IFNLR) .
Biological Properties

Interferons exhibit several key biological properties:

  • Expression Patterns: Interferons are produced by various cell types, including leukocytes, fibroblasts, and epithelial cells, in response to viral infections .
  • Tissue Distribution: They are distributed across different tissues, with plasmacytoid dendritic cells being prolific producers of IFN-α and IFN-β .
  • Key Biological Properties: Interferons induce an antiviral state in cells, enhance the immune response, and regulate cell growth and differentiation .
Biological Functions

Interferons play several crucial roles in the immune system:

  • Primary Biological Functions: They inhibit viral replication, activate immune cells such as natural killer cells and macrophages, and increase antigen presentation by up-regulating major histocompatibility complex (MHC) molecules .
  • Role in Immune Responses: Interferons are essential for the innate immune response, providing the first line of defense against viral infections .
  • Pathogen Recognition: They help in recognizing and responding to pathogens by activating various immune cells and signaling pathways .
Modes of Action

Interferons exert their effects through several mechanisms:

  • Binding Partners: They bind to specific receptors on the surface of target cells, initiating a signaling cascade .
  • Downstream Signaling Cascades: This binding leads to the activation of various genes that produce antiviral proteins, inhibit viral replication, and modulate the immune response .
  • Interaction with Other Molecules and Cells: Interferons interact with other cytokines and immune cells to coordinate a comprehensive immune response .
Regulatory Mechanisms

The expression and activity of interferons are tightly regulated:

  • Transcriptional Regulation: Interferon regulatory factors (IRFs) play a crucial role in the transcriptional regulation of interferon genes .
  • Post-Translational Modifications: Interferons undergo various post-translational modifications that affect their stability, activity, and interactions with other proteins .
  • Control of Expression: The production of interferons is induced by the recognition of viral components through pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) .
Applications

Interferons have several applications in biomedical research and medicine:

  • Biomedical Research: They are used to study viral infections, immune responses, and cancer biology .
  • Diagnostic Tools: Interferons can be used as biomarkers for certain diseases and infections .
  • Therapeutic Strategies: Interferons are used in the treatment of various conditions, including viral infections (e.g., hepatitis B and C), multiple sclerosis, and certain cancers .
Role in the Life Cycle

Interferons play a role throughout the life cycle, from development to aging and disease:

  • Development: They are involved in the development of the immune system and the establishment of immune responses .
  • Aging: The production and response to interferons can change with age, affecting immune function .
  • Disease: Dysregulation of interferon production or signaling can contribute to various diseases, including autoimmune disorders and chronic inflammatory conditions .
© Copyright 2024 Thebiotek. All Rights Reserved.